Search Results 421-430 of 16810 for GLP-1 agonists

  1. Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea - Mayo Clinic

    GLP1 receptor agonists for weight loss, unless reached stable dose and stable weight (<4lbs weight change per month) for 3+ months; Other carbonic anhydrase ...

  2. Glycopyrrolate and formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... Clean the inhaler 1 time each ...

  3. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

    Using one of ... If using noninsulin glucose-lowering medications (such as GLP-1receptor agonist ... Type 1 diabetes; Use of an FDA-approved or non-FDA ...

  4. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  5. A Study to Evaluate the Effectiveness and Safety of Glepaglutide in the Treatment of Short Bowel Syndrome - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... Use of GLP-1, GLP-2, human growth hormone (HGH), somatostatin, or analogs ...

  6. Study To Evaluate Efficacy And Safety Of ONL1204 In Patients With GA Associated With AMD - Mayo Clinic

    Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and ...

  7. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

    The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy ...

  8. A Study To Evaluate The Use Of MANP In Patients With Hypertension And Metabolic Syndrome - Mayo Clinic

    1. During the early phases (phases 1 and 2) ... Serum HDL cholesterol <40 mg/dL (1 mmol/L) in men and <50 ... Oral or inhaled sympathomimetics (β-agonists) ...

  9. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Dose escalation study to determine the maximum tolerated dose of NEOD001 in approximately 30 subjects with AL amyloidosis. Expansion phase to evaluate safety, ...

  10. Atypical antidepressants - Mayo Clinic

    They are each unique medications that work in different ways from one another. How atypical antidepressants work. Atypical antidepressants ease depression by ...